Short answer is… because we designed the newly approved trials to hit a primary endpoint we have already hit. Therefore reducing the chances of not hitting the primary endpoint to almost nil. That’s what a improved trial design looks like. We have learned from our trials and now we have put together a trial for approval of not only a EUA but a BLA if we do in fact hit our primary endpoint.

Answer me this… why are so many pessimistic bashers on all of the chat boards? When it is futile to even considering replacing Nader or management. You can plainly see when they are knocking it out of the park?

You guys just look silly and other adjectives I won’t release on you guys. But know they aren’t kind in describing the 13d groupies… get a life… your wasting your time on the this chat board…we were expecting a 90%+ vote in favor of the same Board of Directors and that board will undoubtedly re-elect Nader. Nobody wants change when management is doing so well progressing this company into revenue world wide. If someone else stepped in at this point it would be like losing another year of time while they gather what is even happening. It would be a terrible move to start over when we are on the cusp.

Not Respectfully back at you!